REQUEST A DEMO
Total
USD $0.00
Search more companies

Unifarma SIA (Latvia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Unifarma SIA Profile Updated: May 24, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Unifarma SIA is an enterprise in Latvia, with the main office in Riga. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. Unifarma SIA was incorporated on December 15, 1999. Unifarma SIA currently employs 16 (2024) people. From the latest financial highlights, Unifarma SIA reported a net sales revenue increase of 28.8% in 2025. During that time, Unifarma SIA’s total assets grew by 13.8%. Unifarma SIA’s net profit margin decreased by 17.27% in 2025.

Headquarters
Vangazu iela 23
Riga; Riga; Postal Code: 1024

Contact Details: Purchase the Unifarma SIA report to view the information.

Basic Information
Total Employees:
Purchase the Unifarma SIA report to view the information.
Registered Capital:
Purchase the Unifarma SIA report to view the information.
Financial Auditors:
Purchase the Unifarma SIA report to view the information.
Incorporation Date:
December 15, 1999
Key Executives
Purchase this report to view the information.
Member of Management Board
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Aptiekas Produkcija SIA
100%
Company Performance
Financial values in the chart are available after Unifarma SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
28.8%
Total Operating Revenue
24.26%
Operating Profit
-24.56%
EBITDA
-24.56%
Net Profit/Loss for the Period
-23.21%
Total Assets
13.8%
Total Equity
17.93%
Operating Profit Margin
-17.88%
Net Profit Margin
-17.27%
Return on Equity (ROE)
-9.52%
Quick Ratio
0.16%
Cash Ratio
0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?